Evidence from a pilot study suggests that blood biomarkers obtained from teenagers may identify those at risk for early onset major depressive disorder.
Evidence from a pilot study suggests that blood biomarkers obtained from teenagers may identify those at risk for early onset major depressive disorder (MDD). These genetic markers can also distinguish between major depression and depression combined with anxiety disorder.
The prevalence of MDD in late adolescence and young adulthood has been estimated at 17% to 25%. The discovery of biologic markers for MDD could improve the accuracy of the diagnosis, which can be challenging because of teenagers' fluctuating moods, and may perhaps lead to enhanced individualized care.
Researchers looked at 26 candidate blood biomarkers in 15- to 19-year-olds, 14 of whom had MDD and 14 of whom had no depressive disorder. They found differences in the expression of 11 genes that differentiated those with MDD from those without.
Teenagers with depression who remain untreated have a higher risk of substance abuse, physical illness, suicide, and social maladjustment.
Pajer K, Andrus BM, Gardner W, et al. Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression. Transl Psychiatry. 2012;2:e101.
Prehospital medication dosing deviates from recommended weight-based guidelines
July 20th 2023Lorazepam, diazepam, midazolam, fentanyl, hydromorphone, morphine, ketorolac, epinephrine, diphenhydramine, and methylprednisolone were investigated in the study. Overall, the most common type of deviation was an underdose.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Does stimulant medication for pediatric ADHD affect adult height?
November 8th 2022A recent review found that multiple clinical trials indicated a reduction in adult height potential for children with long-term use of stimulant medication for treatment of ADHD, but other studies conflict with this data.
Diagnosing and treating the adolescent with irregular menstruation
October 10th 2022At the 2022 AAP National Conference & Exhibition, a professor from the Baylor College of Medicine discusses how to develop an approach to investigate menstrual disturbances for adolescent patients and understand treatment options.